M&A Deal Summary |
|
|---|---|
| Date | 2015-12-30 |
| Target | Clarient |
| Sector | Healthcare Services |
| Buyer(s) | NeoGenomics |
| Sellers(s) | GE Healthcare |
| Deal Type | Divestiture |
| Deal Value | 275M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 2001 |
| Sector | Life Science |
| Employees | 2,100 |
| Revenue | 592M USD (2023) |
NeoGenomics is a clinical laboratory that specializes in cancer genetics diagnostic testing. The company’s testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology and molecular genetic testing. NeoGenomics was founded in 2001 and is based in Fort Myers, Florida.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 6 |
| Sector (Healthcare Services) | 2 of 3 |
| Type (Divestiture) | 1 of 1 |
| State (California) | 2 of 3 |
| Country (United States) | 2 of 4 |
| Year (2015) | 1 of 1 |
| Size (of disclosed) | 2 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-07-08 |
Path Logic
Carmichael, California, United States Path Logic is a provider of specialized anatomic pathology services to Hospitals and physicians in Northern California. |
Buy | $6M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-10-23 |
Genoptix
Carlsbad, California, United States Genoptix, Inc. is one of the largest hematopathology testing laboratories in the U.S., providing thousands of oncologists and pathologists across the United States with comprehensive testing solutions in hematology and solid tumor molecular profiling. Genoptix, Inc. was founded in 1999 and is based in Carlsbad, California. |
Buy | $126M |
| Category | Company |
|---|---|
| Founded | 1994 |
| Sector | Medical Products |
GE Healthcare, a unit of General Electric Company is a provider of medical technologies and services. GE Healthcare has expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, life sciences, drug discovery, and biopharmaceutical manufacturing technologies. GE Healthcare is based in Westborough, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 11 |
| Sector (Healthcare Services) | 1 of 1 |
| Type (Divestiture) | 6 of 11 |
| State (California) | 1 of 1 |
| Country (United States) | 5 of 10 |
| Year (2015) | 1 of 1 |
| Size (of disclosed) | 4 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-12-30 |
NeoGenomics
Fort Myers, Florida, United States NeoGenomics is a clinical laboratory that specializes in cancer genetics diagnostic testing. The company’s testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology and molecular genetic testing. NeoGenomics was founded in 2001 and is based in Fort Myers, Florida. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-07-13 |
Biosafe Group SA
Eysins, Switzerland Biosafe Group SA is a supplier of integrated cell bioprocessing systems for the rapidly growing cell therapy and regenerative medicine industry. Company has a 20 year track-record in automated cell processing and is a recognized leader in the field with reliable applications in bioprocessing, regenerative medicine and stem cell banking. Its proprietary products offer significant advantages over conventional processing tools, with closed fluid pathways, built-in traceability and single-use consumables. The strong strategic fit and complementary business models of GE Healthcare’s Life Sciences business and Biosafe combined with expanded capabilities in product development and commercial reach, will offer significant customer and ultimately patient benefits. |
Buy | - |
